摘要:
2-(4,5-Dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole derivatives and their pharmaceutically acceptable salts are useful an antidiabetic agents.
摘要:
Imidazoline derivatives of formula (I) ##STR1## in which n is 1 or 2, R is hydrogen, C.sub.1 -C.sub.3 alkyl or allyl group, and X is hydrogen, halogen atom, methyl or methoxy, in the form of enantiomers or mixtures thereof, and their pharmaceutically acceptable acid addition salts are useful as .alpha..sub.2 -antagonists.
摘要:
A compound which is a pyrido[3,4-b]derivative of formula (I) ##STR1## in which R is a hydrogen atom or an alkyl carbonyl, arylalkylcarbonyl or arylcarbonyl group of formula COR.sub.1 wherein R.sub.1 is a C.sub.1 -C.sub.6 alkyl group, a benzyl group or a phenyl group unsubstituted or substituted with 1 to 3 substituents chosen from halogen atoms and trifluoromethyl, C.sub.1 -C.sub.3 alkyl and C.sub.1 -C.sub.3 alkoxy groups or R is an alkoxycarbonyl or benzyloxycarbonyl group of formula COOR.sub.2 wherein R.sub.2 is a C.sub.1 -C.sub.6 alkyl group or a benzyl group, or R is a substituted aminocarbonyl group of formula CONHR.sub.3 wherein R.sub.3 is a C.sub.1 -C.sub.6 alkyl group or a phenyl group, or R is an arylsulphonyl group of formula SO.sub.2 R.sub.4 wherein R.sub.4 is a phenyl group, or a pharmacologically acceptable acid addition salt thereof useful for treating hypertension, depressive state or anxiety state.
摘要翻译:化合物,其是式(I)的吡啶并[3,4-b]衍生物,其中R是氢原子或式COR1的烷基羰基,芳基烷基羰基或芳基羰基,其中R1是C1- C6烷基,苄基或未取代的或被1至3个选自卤素原子和三氟甲基,C1-C3烷基和C1-C3烷氧基的取代基取代的苯基,或者R是式COOR2的烷氧基羰基或苄氧基羰基,其中R2是 C 1 -C 6烷基或苄基,或R是式CONHR 3的取代的氨基羰基,其中R 3是C 1 -C 6烷基或苯基,或R是式SO 2 R 4的芳基磺酰基,其中R 4是苯基 ,或其可用于治疗高血压,抑郁状态或焦虑状态的药理学上可接受的酸加成盐。
摘要:
Pyrrolo[3,2,1-hi]indole derivatives, in the form of racemates or optically active isomers, of formula (I) ##STR1## in which R is a hydrogen atom or C.sub.1 -C.sub.4 alkyl and R.sub.1 and R.sub.2, which may be the same or different, are hydrogen, halogen or C.sub.1 -C.sub.4 alkyl and their pharmaceutically acceptable acid addition salts are useful as .alpha..sub.2 -antagonists.
摘要:
A benzazepine derivative which is a compound of formula (I): ##STR1## in which each of m and n denotes the number 1, oreach of m and n denotes the number 2, orm denotes the number 3 and n denotes the number 1; and R denotes hydrogen or a group of formula --Z--R' in which Z denotes a --CO-- or --CH.sub.2 -- group and R' denotes a phenyl group which is unsubtituted or substituted with from one to three substituents selected from halogen atoms, linear or branch (C.sub.1 -C.sub.3) alkyl groups and linear or branched (C.sub.1 -C.sub.3) alkoxy groups, or a pharmacologically acceptable acid addition salt.
摘要:
Compounds of the formula: ##STR1## in which R.sub.1 represents a hydroxy group, a C.sub.1 -C.sub.4 alkoxy group or an amino group of general formula --NR.sub.4 R.sub.5 in which R.sub.4 and R.sub.5 each represent, independently of each other, a hydrogen atom, a straight or branched C.sub.1 -C.sub.4 alkyl group, an allyl group or a methoxyethyl group, or alternatively --NR.sub.4 R.sub.5 represents a heterocycle containing 3 to 6 carbon atoms,Y represents a thienyl group optionally substituted by an alkyl group, andX represents a hydrogen or halogen atom,are useful as anticonvulsants and auxiolytics.
摘要:
A compound of formula (I) ##STR1## in which R is a benzyl, benzoyl, 3-chlorobenzoyl, 3-methylbenzoyl or (C.sub.1 -C.sub.6 alkoxy)carbonyl group, or a pharmacologically acceptable acid addition salt thereof.
摘要:
Compounds corresponding to the formula (I) as defined in the disclosure, as well as methods for making such compounds, intermediates employed in such methods, pharmaceutical compositions containing the compounds of the invention, and methods of treatment using them.
摘要:
Compounds corresponding to the formula (I) as defined in the disclosure, as well as methods for making such compounds, intermediates employed in such methods, pharmaceutical compositions containing the compounds of the invention, and methods of treatment using them.
摘要:
The present invention discloses and claims a compound of general formula (I) wherein A, X and R2 are as described herein. Also disclosed and claimed is application of this compound in a variety of therapeutic applications.